Community Home

Latest Discussion Posts

Please login to see all eligible discussion postings

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Announcements List

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Community Blogs

  • What happens when we stop GLP-1 receptor agonists? Author: Shelley Jeon, PharmD Candidate 2025, Northeastern University School of Pharmacy Reviewer: Courtney Cameron, PharmD, BCACP What data are available on weight regain ...

  • Fructosamine Testing for Glycemic Control: When and Why to Order Fructosamine Tests and How to Interpret the Results Author: Emilia Kapcia, PharmD Candidate 2025, Northeastern University School of Pharmacy Reviewer: Courtney Cameron, ...

    1 person recommends this.
  • Title: How does the efficacy of Rybelsus compare to DPP4s and SGLT2s in patients with T2DM? Author: Jiwoo Lee, PharmD Candidate 2024, Northeastern University School of Pharmacy Reviewer: Courtney Cameron, PharmD, BCACP ...

  • Stretched Thin On GLP-1/GIP Agonists: Tips for navigating the national shortages By: Bharathi Ravikumar, PharmD and Kaitlyn Craddock, PharmD, BCACP GLP-1 agonists and GLP-1/GIP agonist injectable medications have exploded in popularity across ...

  • Glucagon-like peptide-1 receptor agonists (GLP-1RA) and Diabetic Retinopathy Prepared by: Emily Short, PharmD, PGY-1 Pharmacy Resident, Boston Medical Center What is diabetic retinopathy? Diabetic retinopathy (DR) is a microvascular ...

Latest Shared Files

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.